Cerecin Pte Ltd., of Singapore, appointed Christopher Chen and Chua Nam-Hai to its scientific advisory board. Chen is an associate professor in the Department of Pharmacology at the National University of Singapore's Yong Loo Lin School of Medicine (NUS Medicine). Read More
Otsuka Pharmaceutical Co. Ltd., of Tokyo, and Proteus Digital Health Inc., of Redwood City, Calif., expanded their partnership for Abilify Mycite (aripiprazole tablets with sensor) to include the development and commercialization of digital medicines for mental health over the next five years. Read More
Wyss Institute researchers have shown that gold nanoparticles can help extend the half-life of investigational cytokine interleukin 4 (IL-4), which is known to boost anti-inflammatory activity but degrades too quickly when injected alone to produce the desired effect. Read More
Next week could usher in the beginning of a new era as the world's biggest blockbuster drug meets biosimilar competition for the first time in Europe. Read More
HONG KONG – Chinese biotech firm Origimed Co. Ltd., of Shanghai, is taking part in building China's first cancer big data platform with two oncology organizations to gather genetic data of the Chinese population. That will give doctors more precise information to diagnose cancer and customize treatment. Read More
HONG KONG – China's State Medical Insurance Administration has added 17 cancer drugs to the National Reimbursement Drug List (NRDL) covered by its national basic health insurance, work-related injury insurance and maternity insurance, slashing their prices as much as 74 percent. Read More
SHANGHAI – Alphamab Oncology Co. Ltd., of Suzhou, China, has kicked off a phase I study in Australia for KN-046, a PD-L1/CTLA-4, a potentially first-in-class bispecific that combines two domain antibodies fused with IgG Fc. Read More
